Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
AstraZeneca
Colorcon
McKesson
Mallinckrodt

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for BTA798

See Plans and Pricing

« Back to Dashboard

What is the drug development status for BTA798?

BTA798 is an investigational drug.

There have been 5 clinical trials for BTA798. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2015.

The most common disease conditions in clinical trials are Infection, Communicable Diseases, and Respiratory Tract Infections. The leading clinical trial sponsors are Biota Scientific Management Pty Ltd, Biota Pharmaceuticals, Inc., and Vaxart.

There are eleven US patents protecting this investigational drug and fifty-three international patents.

Recent Clinical Trials for BTA798
TitleSponsorPhase
A Study to Compare the Oral Bioavailability of Single Doses of Three Vapendavir Drug Formulations in Healthy VolunteersAviragen TherapeuticsPhase 1
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus InfectionBiota Pharmaceuticals, Inc.Phase 2
A Drug-Drug Interaction Study to Evaluate the Effect of Vapendavir on the Pharmacokinetics of Midazolam in Healthy Male and Female VolunteersBiota Scientific Management Pty LtdPhase 1

See all BTA798 clinical trials

Clinical Trial Summary for BTA798

Top disease conditions for BTA798
Top clinical trial sponsors for BTA798

See all BTA798 clinical trials

US Patents for BTA798

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
BTA798   Start Trial Antiviral agents Biota Scientific Management Pty Ltd (Notting Hill, AU)   Start Trial
BTA798   Start Trial Antiviral agents Biota Scientific Managment Pty. Ltd. (Notting Hill, AU)   Start Trial
BTA798   Start Trial Antiviral agents Biota Scientific Management Pty. Ltd. (Notting Hill, AU)   Start Trial
BTA798   Start Trial Antiviral agents Biota Scientific Management Pty Ltd (Notting Hill, AU)   Start Trial
BTA798   Start Trial Antiviral agents Biota Scientific Management Pty. Ltd. (Notting Hill, AU)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for BTA798

Drugname Country Document Number Estimated Expiration Related US Patent
BTA798 Austria 504579 2020-12-18   Start Trial
BTA798 Australia 2002221344 2020-12-18   Start Trial
BTA798 Australia 2134402 2020-12-18   Start Trial
BTA798 Brazil 0116299 2020-12-18   Start Trial
BTA798 Brazil PI0116299 2020-12-18   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Merck
Harvard Business School
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.